Bipartisan Criticism of Health Care Consolidation Reaches New Heights

Momentum to roll back health care consolidation is building in Washington, D.C. Lawmakers in both parties have attacked the trend in recent weeks, and prominent senators trained their sights on MultiPlan Corp., with one senator accusing the firm and its insurer clients of collusion, a violation of antitrust law.

Given all the scrutiny on health care consolidation, one antitrust expert says Congress might be motivated to grant federal authorities the ability to review the kind of health care transactions that federal regulators are currently unable to block.

Two committees of the House of Representatives held hearings on health care consolidation last week, and both featured continuous attacks by members of both parties on routine health care dealmaking.

0 Comments
© 2024 MMIT
Peter Johnson

Peter Johnson

Peter has worked as a journalist since 2011 and has covered health care since 2020. At AIS Health, Peter covers trends in finance, business and policy that affect the health insurance and pharma sectors. For Health Plan Weekly, he covers all aspects of the U.S. health insurance sector, including employer-sponsored insurance, Medicaid managed care, Medicare Advantage and the Affordable Care Act individual marketplaces. In Radar on Drug Benefits, Peter covers the operations of (and conflicts between) pharmacy benefit managers and pharmaceutical manufacturers, with a particular focus on pricing dynamics and market access. Before joining AIS Health, Peter covered transportation, public safety and local government for various outlets in Seattle, his hometown and current place of residence. He graduated with a B.A. from Colby College.

Related Posts

huamana
December 1

The Next Big Deal? Rumored Cigna-Humana Talks Raise PBM Overlap Question

READ MORE
scales-of-justice
July 21

New Antitrust Regs Could Slow Health Care Deals, Limit Data Sharing

READ MORE
wall-street-logo
April 14

Wall Street Analysts Have Little Faith That Feds Can Slow Health Care M&A

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today